Ultrasound-enabled precision delivery for Parkinson’s disease

Focused ultrasound to support localized, repeatable and biologically meaningful delivery of GDNF to Parkinson’s-relevant brain regions.

Explore Program

Collaborate With Us

Ultrasound-enabled precision delivery for Parkinson’s disease

Focused ultrasound to support localized, repeatable and biologically meaningful delivery of GDNF to Parkinson’s-relevant brain regions.

Explore Program

Collaborate With Us

OUR SOLUTION

Implantable acoustofluidics for targeted neuroprotection

Implantable acoustofluidics for targeted neuroprotection

Designed to deliver GDNF directly to the substantia nigra. Combining image-guided targeting, localized acoustic stimulation, active microfluidic delivery, and real-time dopamine sensing, the system aims to improve therapeutic distribution while limiting exposure to surrounding tissue.

Designed to deliver GDNF directly to the substantia nigra. Combining image-guided targeting, localized acoustic stimulation, active microfluidic delivery, and real-time dopamine sensing, the system aims to improve therapeutic distribution while limiting exposure to surrounding tissue.

01

Substantia nigra
targeting

Image-guided placement near Parkinson’s-relevant tissue.

02

Controlled GDNF
delivery

Active acoustofluidic pumping for localized distribution.

03

Real-time dopamine
sensing

Functional feedback for future adaptive treatment.